Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Baseline risk factors associated with immune related adverse events and atezolizumab
K Madjar, R Mohindra, G Durán-Pacheco… - Frontiers in …, 2023 - frontiersin.org
Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer
patients in the last decade, but immune-related adverse events (irAEs) pose significant …
patients in the last decade, but immune-related adverse events (irAEs) pose significant …
Immune-based cancer treatment: addressing disparities in access and outcomes
Avoidable differences in the care and outcomes of patients with cancer (ie, cancer care
disparities) emerge or worsen with discoveries of new, more effective approaches to cancer …
disparities) emerge or worsen with discoveries of new, more effective approaches to cancer …
Skin manifestations associated with checkpoint inhibitors
G Nazzaro, S Buffon, S Giacalone… - JEADV Clinical …, 2022 - Wiley Online Library
Immune checkpoint inhibitors (ICIs) are a relatively novel class of drugs whose
administration has been approved for several malignancies. Adverse events are quite …
administration has been approved for several malignancies. Adverse events are quite …
Pericardial toxicities associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
Z Ma, J Pei, X Sun, L Liu, W Lu, Q Guo, J Lyu… - Frontiers in …, 2021 - frontiersin.org
Introdution: Immune checkpoint inhibitors (ICIs) have significantly improved clinical
outcomes for a wide range of cancers but can also lead to serious or fatal immune-related …
outcomes for a wide range of cancers but can also lead to serious or fatal immune-related …
Characterising immune-related adverse events in different types of cancer among Chinese patients receiving immune checkpoint inhibitors
Q Zhang, J Chen, N Tsai, X Zhu, M Zhao, L Meng… - Scientific Reports, 2024 - nature.com
Immune checkpoint inhibitors (ICIs) have been approved for monotherapy and combined
therapy with chemotherapy and/or radiotherapy in China since 2018. The number of patients …
therapy with chemotherapy and/or radiotherapy in China since 2018. The number of patients …
Increased presentation for vitiligo cutaneous immune related adverse events in Hispanic patients
ZK Momin, JG Gill, M Heberton - Archives of Dermatological Research, 2024 - Springer
MH drafted, revised, and reviewed the manuscript. ZM performed the statistical analysis
which was reviewed by MH and JG All authors made substantial contributions to the …
which was reviewed by MH and JG All authors made substantial contributions to the …
Pathologies malignes cutanées
P Pitché, A Mahé - Dermatologie de la diversité, 2022 - books.google.com
On doit s' en tenir aux conceptions classiques qui sont que ces tumeurs, si fréquentes sur
peau claire, sont beaucoup plus rares en cas de phototype foncé (V et VI). Ceci reflète …
peau claire, sont beaucoup plus rares en cas de phototype foncé (V et VI). Ceci reflète …
[HTML][HTML] Addressing Healthcare Disparities
L Ha - immunohub.org
My name is Lisa Ha, and I'ma Nurse Practitioner at Northwestern Memorial Hospital in
Chicago, Illinois. I've been practicing for about 5 years, and I specialize in melanoma and …
Chicago, Illinois. I've been practicing for about 5 years, and I specialize in melanoma and …
[ZITATION][C] Chapitre 11-Toxidermies: Influences géographiques et génétiques
D de la Diversité - Elsevier